Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8334372 Modulation of factor 11 expression

Patent 8334372 was granted and assigned to Ionis Pharmaceuticals on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ionis Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83343720

Patent Inventor Names

Susan M. Freier0

Andrew M. Siwkowski0

Brett P. Monia0

Chenguang Zhao0

Hong Zhang0

Jeffrey R. Crosby0

Date of Patent

December 18, 2012

Patent Application Number

125802410

Date Filed

October 15, 2009

Patent Citations Received

‌

US Patent 12012464 Factor XI antibodies and methods of use

‌

US Patent 11918600 Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof

Patent Primary Examiner

‌

Terra Cotta Gibbs

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8334372 Modulation of factor 11 expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API